Company dynamics
- On 26 Jan., 2026, Guangji Pharma released its performance forecast for the year 2025.
- On 30 Jan., 2026, Nengter Tech released its 2025 annual performance forecast.
- On 5 Feb., 2026, NHU raised its export offer for 50% feed-grade vitamin E by 15% to USD7.5/kg, with key producers such as Jilin Beisha Pharma following suit shortly thereafter.
- On 9 Feb., 2026, DSM-Firmenich announced the sale of its animal nutrition and health business to CVC.
- On 4 Feb., 2026, Guangji Pharma passed its vitamin B2 production license inspection; On 12 Feb., it planned to raise up to USD86.09 million from Changjiang Industrial Investment.
Project progress
- EI report for Jiangsu Heyuan Biotech's feed additive project was made public.
- EI report for Jiangsu Lee & Man Chemical's 3,000 t/a vitamin microparticles production project was publicised.
- EI report for Hami Shuoyuan's 2,000 t/a feed-grade Vitamin D3, 2 t/a feed-grade Vitamin D2, and 250 t/a lanolin cholesterol project was released.
The USD/RMB exchange rate in this Report is USD1.00=CNY6.9695 on 2 Feb. 2026, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
